Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B

Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B

The immunogenicity and safety of a new recombinant hepatitis B vaccine from the Instituto Butantan (Butang®) were evaluated in a multicenter, double-blind, prospective equivalence study in three centers in Brazil. Engerix B® was the standard vaccine. A total of 3937 subjects were recruited and 2754...

Full description

Bibliographic Details
Main Authors: Reinaldo Menezes Martins, Gilberta Bensabath, Luiz Claudio Arraes, Maria de Lourdes Aguiar Oliveira, Juliana Custódio Miguel, Glayse Glayde Barbosa, Luiz Antonio Bastos Camacho
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2004-12-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
hepatitis B vaccine
recombinant vaccines
immunization
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000800014

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000800014

Similar Items